-BioMap’s AI drug discovery platform integrates foundational large language models and super-scale computing with cutting-edge biotechnology to discover novel targets and design biologics through a ...
BioMAP® assays are human primary cell-based assays that read out a unique signature of biological activity for every active compound including both drug candidates and a wide range of chemicals. Using ...
Hong Kong, SAR--(Newsfile Corp. - June 24, 2024) - Hong Kong Science Park Corporation (HKSTP) congratulates BioMap, a Park company, on its strategic partnership with the Hong Kong Investment ...
Sanofi has assembled a stable of partnerships to carry out its goal of using artificial intelligence to bolster drug discovery, but those pacts mainly cover small molecule drugs. The pharmaceutical ...
Biomap, a biotechnology start-up co-established by Baidu founder Robin Li Yanhong and backed by the Hong Kong government, says it has surpassed Alphabet subsidiary AlphaFold in commercialising ...
MENLO PARK, Calif., March 4, 2026 /PRNewswire/ -- Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced it has expanded the ...
Researchers have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical extracts from natural sources. Researchers at the ...
Robotic equipment at the UCSC Chemical Screening Center was used to screen natural product extracts for novel antibiotics. Researchers at the University of California, Santa Cruz, have developed a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results